China Universal Asset Management Co., Ltd. Nurix Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.17 Billion
- Q3 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 13,400 shares of NRIX stock, worth $171,520. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,400
Previous 15,312
12.49%
Holding current value
$171,520
Previous $174,000
29.31%
% of portfolio
0.01%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding NRIX
# of Institutions
186Shares Held
77.3MCall Options Held
99.8KPut Options Held
11.3K-
Black Rock Inc. New York, NY6.82MShares$87.3 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.06MShares$77.5 Million1.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.49MShares$57.5 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$49.7 Million0.29% of portfolio
-
Commodore Capital LP New York, NY3.78MShares$48.4 Million2.23% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $603M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...